Akses terbuka
Jurnal
SINTA 1
State Responsibility for Access and Availability of Patented Drugs for Public Health
Yuridika · Vol. 38 No. 2 (2022) · hlm. 219–242
ISSN 2528-3103, 0215-840X
Terbit 2022-05-01
Penerbit Universitas Airlangga
Bahasa eng
Abstrak
Article 28H and Article 34 of the 1945 Constitution of the Republic of Indonesia stipulate that fulfilling the health rights of Indonesian citizens is the responsibility of the state. Human rights require that individuals have access to the availability of medicines in society. The high price of medicines, especially patent medicines, results in limited access and availability of essential medicines. This study uses normative legal research methods, with a statutory approach, and a conceptual approach. The purpose of this study is to examine and analyze the state's goals in fulfilling the right to health as a human right by the state as well as access and availability of patented drugs to fulfill the right to health. In addition to ensuring the availability of complete medicines in sufficient quantity, quality, affordable and easily accessible to the public, the government is also responsible for protecting the rights of inventors as long as the drugs are still under patent protection. To balance these two rights, the government plays the role of provider, regulator, entrepreneur and umpire.
Jaringan kolaborasi para penulis
8 penulis ·
16 tautan kepenulisan bersama
· 3 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Universitas Airlangga National Taipei University of Business Afiliasi tidak diketahui
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.
Sumber metadata: OAI-PMH (metadata jurnal) https://e-journal.unair.ac.id/YDK/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 10 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title xml:lang="en-US">State Responsibility for Access and Availability of Patented Drugs for Public Health</dc:title>
<dc:creator>Muis, Lidya Shery</dc:creator>
<dc:creator>Rahmi Jened</dc:creator>
<dc:creator>Nurul Barizah</dc:creator>
<dc:creator>Go Chin Tjwan</dc:creator>
<dc:subject xml:lang="en-US">State Responsibility</dc:subject>
<dc:subject xml:lang="en-US">Access and Availability of Drugs</dc:subject>
<dc:subject xml:lang="en-US">Patent</dc:subject>
<dc:subject xml:lang="en-US">Health Rights</dc:subject>
<dc:description xml:lang="en-US">Article 28H and Article 34 of the 1945 Constitution of the Republic of Indonesia stipulate that fulfilling the health rights of Indonesian citizens is the responsibility of the state. Human rights require that individuals have access to the availability of medicines in society. The high price of medicines, especially patent medicines, results in limited access and availability of essential medicines. This study uses normative legal research methods, with a statutory approach, and a conceptual approach. The purpose of this study is to examine and analyze the state's goals in fulfilling the right to health as a human right by the state as well as access and availability of patented drugs to fulfill the right to health. In addition to ensuring the availability of complete medicines in sufficient quantity, quality, affordable and easily accessible to the public, the government is also responsible for protecting the rights of inventors as long as the drugs are still under patent protection. To balance these two rights, the government plays the role of provider, regulator, entrepreneur and umpire.</dc:description>
<dc:publisher xml:lang="en-US">Universitas Airlangga</dc:publisher>
<dc:date>2022-05-01</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://e-journal.unair.ac.id/YDK/article/view/43007</dc:identifier>
<dc:identifier>10.20473/ydk.v38i2.43007</dc:identifier>
<dc:source xml:lang="en-US">Yuridika; Vol. 38 No. 2 (2023): Volume 38 No 2 May 2023; 219-242</dc:source>
<dc:source>2528-3103</dc:source>
<dc:source>0215-840X</dc:source>
<dc:language>eng</dc:language>
<dc:relation>https://e-journal.unair.ac.id/YDK/article/view/43007/25712</dc:relation>
<dc:rights xml:lang="en-US">Copyright (c) 2023 Lidya Shery Muis, Rahmi Jened, Nurul Barizah</dc:rights>
<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>
Sitasi dan pengindeksan
OpenAlex
Terindeks
lewat DOI
11 sitasi
Crossref
Belum diperiksa
Jumlah menurut tiap indeks pada 13 Nov 2026; setiap indeks menghitung sitasi dengan cara berbeda.
OpenAlex juga mencatat karya ini di: crossref.
Sitasi artikel ini
APA 7
Muis, L. S., Jened, R., Barizah, N., & Tjwan, G. C. (2022). State Responsibility for Access and Availability of Patented Drugs for Public Health. Yuridika, 38(2), 219–242. https://doi.org/10.20473/ydk.v38i2.43007
Salin
IEEE
L. S. Muis, R. Jened, N. Barizah, and G. C. Tjwan, “State Responsibility for Access and Availability of Patented Drugs for Public Health,” Yuridika, vol. 38, no. 2, pp. 219–242, 2022, doi: 10.20473/ydk.v38i2.43007.
Salin
Dibuat dari metadata jurnal; periksa nama penulis sebelum dipakai.